These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 23539872)
1. [Nasal decongestants and eye drops: keep out of children's reach!]. Poulin-Chartrand S Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872 [No Abstract] [Full Text] [Related]
2. Bilateral acute angle-closure glaucoma after use of Fenox nasal drops. Khan MA; Watt LL; Hugkulstone CE Eye (Lond); 2002 Sep; 16(5):662-3. PubMed ID: 12194094 [No Abstract] [Full Text] [Related]
3. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa]. Knipping S; Holzhausen HJ; Riederer A; Bloching M HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462 [TBL] [Abstract][Full Text] [Related]
4. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa]. Bielenberg J Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138 [No Abstract] [Full Text] [Related]
5. [Rhinitis medicamentosa, an increasing problem. Do nose drops adversely affect bacterial infections?]. Wilhelmson B Lakartidningen; 1994 Dec; 91(49):4635-6. PubMed ID: 7808178 [No Abstract] [Full Text] [Related]
6. Reversible cardiomyopathy due to chronic use of xylometazoline topical nasal spray. Figueiras-Graillet LM; Martínez-Sellés M; Perez-David E; Fernandez-Avilés F Int J Cardiol; 2013 Apr; 164(2):e17-8. PubMed ID: 23079093 [No Abstract] [Full Text] [Related]
7. [Mobitz I after accidental ingestion of eyedrops]. Martínez-Albaladejo M; Alcázar-Gambín J; Melgares de Aguilar Y Mata JM; García-Navarro J An Med Interna; 1996 Jul; 13(7):359-60. PubMed ID: 8962991 [No Abstract] [Full Text] [Related]
8. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Graf P Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860 [TBL] [Abstract][Full Text] [Related]
10. Acute and chronic conjunctivitis due to over-the-counter ophthalmic decongestants. Soparkar CN; Wilhelmus KR; Koch DD; Wallace GW; Jones DB Arch Ophthalmol; 1997 Jan; 115(1):34-8. PubMed ID: 9006422 [TBL] [Abstract][Full Text] [Related]
11. The "nose drop nose" due to oxymetazoline (Afrin) and other topical vasoconstrictors. Feinberg AR; Feinberg SM IMJ Ill Med J; 1971 Jul; 140(1):50-2. PubMed ID: 4104967 [No Abstract] [Full Text] [Related]
13. Exposure to antazoline-naphazoline eye drops during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study. Thomseth V; Cejvanovic V; Jimenez-Solem E; Poulsen HE; Utheim TP; Andersen JT Acta Ophthalmol; 2019 Aug; 97(5):505-509. PubMed ID: 30479070 [TBL] [Abstract][Full Text] [Related]
14. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis]. Dorn M; Hofmann W; Knick E HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532 [TBL] [Abstract][Full Text] [Related]
15. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray. Loewen AH; Hudon ME; Hill MD CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461 [TBL] [Abstract][Full Text] [Related]
16. Ischemic stroke in a man with naphazoline abuse history. Costantino G; Ceriani E; Sandrone G; Montano N Am J Emerg Med; 2007 Oct; 25(8):983.e1-2. PubMed ID: 17920988 [No Abstract] [Full Text] [Related]
17. Branch retinal artery occlusion after excessive use of nasal spray. Magargal LE; Sanborn GE; Donoso LA; Gonder JR Ann Ophthalmol; 1985 Aug; 17(8):500-1. PubMed ID: 2413795 [TBL] [Abstract][Full Text] [Related]
18. Oxymetazoline solutions inhibit middle ear pathogens and are not ototoxic. Isaacson G; Buttaro BA; Mazeffa V; Li G; Frenz DA Ann Otol Rhinol Laryngol; 2005 Aug; 114(8):645-51. PubMed ID: 16190099 [TBL] [Abstract][Full Text] [Related]
19. Bilateral thalamic stroke due to nasal ephedrine and naphazoline use. Liguori C; Garaci F; Romigi A; Mercuri NB; Marciani MG; Placidi F Neurol Sci; 2015 Jul; 36(7):1285-6. PubMed ID: 25527367 [No Abstract] [Full Text] [Related]